Mina J Bissell

This inventor holds 15 USPTO granted patents and 9 published patent applications and 1 EPO patent, primarily in Cancer Therapeutics. Top assignees: University of California, G.d. Searle & Company. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mina J Bissell. Retrieved from https://idiyas.com/inventor/mina-j-bissell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 9)

% Patents Active = 80.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 72(Granted Patents)

Company Filing History:

14 out of 16,058

University of California

patents

1 out of 1,323

G.d. Searle & Company

patents

Years Active: 1998-2020

Loading Chart...

Areas of Expertise:

Adipogenesis

Oncogenic Signaling

Breast Cancer

Radiation Sensitivity

Dystroglycan

Tumor Cell Growth

Targeted Therapy

Nuclear Structural Proteins

Gene Variants

Phenotype Restoration

Proliferative Disorders

Peptides

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10844102 - Peptides, compositions, and methods for stimulating subcutaneous adipogenesis (2020-11-24),

2. 10766927 - Peptides that stimulate subcutaneous adipogenesis (2020-09-08),

3. 10494402 - Peptides that stimulate subcutaneous adipogenesis (2019-12-03),

4. 9689042 - Use of glycolytic pathways for inhibiting or measuring oncogenic signaling (2017-06-27),

5. 9303088 - Detecting and treating breast cancer resistance to EGFR inhibitors (2016-04-05),

6. 8715653 - Modulation of Rhamm (CD168) for selective adipose tissue development (2014-05-06),

7. 8246952 - Method of increasing radiation sensitivity by inhibition of beta one integrin (2012-08-21),

8. 7666850 - Drug screens based on the newly found role of dystroglycan proteolysis and restoration of dystroglycan function thereof (2010-02-23),

9. 7618627 - Method of increasing radiation sensitivity by inhibition of beta one integrin (2009-11-17),

10. 6982151 - Design of novel assays based on the newly found role of dystroglycan and alpha-dystroglycan proteolysis in tumor cell growth (2006-01-03),

11. 6753154 - Human AZU-1 gene, variants thereof and expressed gene products (2004-06-22),

12. 6287790 - Utilization of nuclear structural proteins for targeted therapy and detection of proliferative and differentiation disorders (2001-09-11),

13. 6123941 - Method for restoration of normal phenotype in cancer cells (2000-09-26),

14. 6004805 - Transcriptional enhancer from milk protein genes (1999-12-21),

15. 5846536 - Restoration of normal phenotype in cancer cells (1998-12-08),

Title: Mina J Bissell: Innovator in Adipogenesis Research

Introduction

Mina J Bissell is a prominent inventor based in Berkeley, CA, known for her significant contributions to the field of adipogenesis. With a total of 15 patents, her work focuses on the development of peptides and compositions that stimulate subcutaneous adipogenesis in mammals.

Latest Patents

Among her latest patents are innovative peptides that stimulate subcutaneous adipogenesis. One patent details peptides that promote this process, while another focuses on peptides ranging from 5 to 14 amino acids in length that also encourage subcutaneous adipogenesis. These advancements have potential applications in various medical and therapeutic fields.

Career Highlights

Mina has had a distinguished career, working with esteemed institutions such as the University of California and G.D. Searle & Company. Her research has paved the way for new understandings in the field of adipose tissue biology.

Collaborations

Throughout her career, Mina has collaborated with notable colleagues, including Eva Ann Turley and Seyed Bahram Bahrami. These partnerships have enriched her research and contributed to her innovative discoveries.

Conclusion

Mina J Bissell's work in the field of adipogenesis exemplifies the impact of innovative research on health and medicine. Her contributions continue to inspire advancements in the understanding of fat tissue biology and its implications for human health.

Profile summary based on public USPTO records.